v3.25.4
Income Taxes - Schedule of Deferred tax assets and liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:    
Capital loss carryforward $ 17,566 $ 18,440
Interest 18,811 18,692
Net operating losses 9,916 9,224
Tax credits 2,515 1,381
Investment in Bioventus LLC 2,879 7,362
Transaction costs 655 711
Stock-based compensation 417 283
Research & development 0 50
Accrued liabilities 0 10
Other 342 467
Gross deferred tax asset 53,101 56,620
Valuation allowance (47,579) (51,875)
Total deferred tax assets 5,522 4,745
Deferred income tax liabilities:    
Intangibles 433 564
Gross deferred income tax liabilities 433 564
Net deferred tax asset $ 5,089 $ 4,181